There are 2789 resources available
912P - Results of a randomized phase II study comparing pembrolizumab with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115)
Presenter: Viktor Gruenwald
Session: ePoster Display
913P - Apatinib for heavily pretreated recurrent and/or metastatic head and neck squamous cell carcinoma: Updated analysis
Presenter: kunyu yang
Session: ePoster Display
914P - Impact of induction chemotherapy (ICT) in borderline resectable or unresectable locally advanced oral squamous cell carcinoma (OSCC)
Presenter: Divya Kukreja
Session: ePoster Display
915P - Carboplatin in combination with three weekly paclitaxel as first line therapy in patients with recurrent/metastatic head and neck cancers: A regional cancer center experience
Presenter: Pooja Babbar
Session: ePoster Display
916P - Impact of sarcopenia (S) on efficacy and toxicity of nivolumab (N) in patients (pts) with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) in TOPNIVO (T) study
Presenter: Leonardo Muratori
Session: ePoster Display
917P - Head and neck cancer patients under (chemo-)radiotherapy undergoing nutritional intervention: Results from the prospective randomized HEADNUT-trial
Presenter: Anna Finger
Session: ePoster Display
CN3 - The effect of using interactive mobile application for management of chemotherapy induced nausea and vomiting in children: Randomized controlled study
Presenter: Remziye Semerci
Session: ePoster Display
918P - Impact of locally advanced head and neck cancer treatment: Is there a role for exercise? FIT4TREAT
Presenter: Ines Leao
Session: ePoster Display
919P - Survival impact of nutritional status of locally advanced head and neck cancer squamous cell carcinoma (HNSCC) patients treated with chemoradiotherapy: A prospective observational study
Presenter: Ratchadakorn Meesart
Session: ePoster Display